Credit Suisse Ag/ Rotates From Mega‑Cap AI To Defensives In 2024-Q1

The biggest incremental bet is a near-tripling of Walmart exposure, with Walmart now at 0.33% of the book after a +193.3% lift in shares and a roughly $228.1M capital add. That is a blunt statement that if the consumer slows, they’d rather own the price leader with scale and traffic than higher-beta discretionary names.

On the financial side, they continue to lean into UBS, already a top holding at 2.80% and still increased by 4.1% (about $114.8M more exposure). That looks like a multi-quarter conviction thesis on a recapitalized European champion with capital return leverage.

Health care is the other clear winner in the add list. They boosted Eli Lilly (+4.5%, about $53.1M), Alcon (+2.2%, about $27.3M) and AbbVie (+3.9%, around $18.5M), while also adding to Thermo Fisher (+5.5%, about $26.2M). Altogether, this is a coherent push into pharmaceuticals and life-science tools where earnings durability and pricing power can offset whatever volatility comes out of tech and cyclicals.

Even the modest increase in the S&P 500 ETF IVV (up 0.3%) fits the pattern: a slight thickening of broad-market ballast as they re-balance away from the most extended single-name winners.

The funding sources for this quarter’s defensiveness are exactly what you’d expect: the prior cycle’s mega-cap tech and AI leaders. Credit Suisse cut Apple by 9.1% (about $332.3M), Microsoft by 4.3% (around $258.7M) and Amazon by 8.2% (roughly $206.0M), plus meaningful trims to both Alphabet share classes and Nvidia.

Within semis, the most aggressive move is in AMD, where they slashed the position by 20.2% and nearly $99.0M, and Intel, which was cut by 13.3%. That reads as a view that second-tier AI hardware and turnaround stories are less attractive on a risk/reward basis than the core platforms they still hold.

They also trimmed Visa by 9.7% (about $113.6M), along with steady step-downs in high-quality but fully valued compounders like S&P Global (-13.9%), Danaher (-20.3%) and a swath of consumer and media names such as Netflix (-11.3%), Disney (-9.4%), McDonald’s (-7.4%) and Costco (-3.9%). The message: keep the structural winners, but shrink the tail risk and valuation froth to free up capital for more defensive, yield-anchored exposures.

On paper, the sector moves look modest: technology drops from an estimated 48.19% to 47.46% of the top-50, while health care rises from 11.94% to 12.42% and finance from 9.47% to 9.77%. But when a tech-heavy book like this one sells across MSFT, NVDA, AAPL, GOOGL, AMZN and AMD in one quarter, that is a deliberate cooling of the highest-expectation growth trade.

Consumer exposure inches up to 12.09%, but the mix inside that bucket is shifting from digital growth (Netflix, Disney, Amazon) toward defensive spend (Walmart, Home Depot, Procter & Gamble). Energy, staples and telecom are roughly flat, acting as ballast rather than active bets.

Financials’ slight increase is concentrated in UBS rather than U.S. money-center banks like JPMorgan, which they cut by 10.2%. That tilt, alongside incremental adds in broad-market ETF IVV and resilient health care names, tells you they are repositioning for a world where rates could stay higher for longer and equity leadership may broaden beyond a handful of AI narratives.

Read across the trades and the thesis is not that AI is over — it’s that the easy, beta-fueled leg of the mega-cap tech trade is behind us. Credit Suisse Ag/ is keeping its tech core but re-underwriting the book toward names that can compound through a more volatile, less liquidity-fueled macro regime.

By upgrading health care and life-science tools, doubling down on UBS, and building Walmart, they are effectively paying an insurance premium: sacrificing a bit of upside in a continued melt-up for significantly better downside protection if growth or margins wobble. The small but notable increase in ETF exposure reinforces that they are more comfortable with broad equity beta than with concentrated exposure to the most crowded stories.

Going forward, watch whether they resume adding to semis and cloud if multiples reset, or continue migrating toward cash-flow and dividend-heavy franchises. For now, the quarter’s message is clear: lock in gains from the winners of 2023, lean into durable cash generators, and keep enough benchmark exposure so that if AI keeps running, they still participate — just without being hostage to a handful of over-owned tickers.